Biochemical diagnosis and localization of pheochromocytoma - Can we reach a consensus?

被引:74
作者
Grossman, Ashley [1 ]
Pacak, Karel
Sawka, Anna
Lenders, Jacques W. M.
Harlander, Debra
Peaston, Robert T.
Reznek, Rodney
Sisson, James
Eisenhofer, Graeme
机构
[1] St Bartholomews Hosp, Dept Endocrinol, London EC1A 7BE, England
[2] NICHHD, Reprod Biol & Med Branch, NIH, Bethesda, MD 20892 USA
[3] Univ Toronto, Dept Med, Toronto, ON, Canada
[4] St Radboud Hosp, Dept Gen Internal Med, Nijmegen, Netherlands
[5] Pheochromocytoma Support Grp, Camden, NY 13316 USA
[6] Freeman Rd Hosp, Dept Clin Biochem, Newcastle Upon Tyne, Tyne & Wear, England
[7] St Bartholomews Hosp, Div Radiol, London EC1A 7BE, England
[8] Univ Michigan Hosp, Dept Radiol, Ann Arbor, MI 48109 USA
[9] NINDS, Clin Neurocardiol Sect, NIH, Bethesda, MD 20892 USA
来源
PHEOCHROMOCYTOMA | 2006年 / 1073卷
关键词
pheochromocytoma; biochemical diagnosis; metanephrines; catecholamines; localization; computed tomography; magnetic resonance imaging; MIBG; positron emission tomography;
D O I
10.1196/annals.1353.038
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Pheochromocytomas can have a highly variable presentation, making diagnosis challenging. To think of the tumor represents the crucial initial step, but establishing the diagnosis requires biochemical evidence of excessive catecholamine production and imaging studies to localize the source. Currently, however, there exist no generally agreed upon guidelines based on which tests and testing algorithms should be used to confirm and locate or exclude a suspected pheochromocytoma. Choice of biochemical tests and imaging studies instead usually depends on institutional experience. At the First International Symposium on Pheochromocytoma (ISP2005), held in Bethesda in October 2005, a panel of experts and patient representatives discussed current problems and available options for tumor diagnosis and localization and formulated recommendations, which were subsequently agreed upon by those in attendance at the meeting. This article summarizes the discussion and recommendations derived from that session.
引用
收藏
页码:332 / 347
页数:16
相关论文
共 54 条
[1]   Genetic testing in pheochromocytoma or functional paraganglioma [J].
Amar, L ;
Bertherat, J ;
Baudin, E ;
Ajzenberg, C ;
Bressac-de Paillerets, B ;
Chabre, O ;
Chamontin, B ;
Delemer, B ;
Giraud, S ;
Murat, A ;
Niccoli-Sire, P ;
Richard, SP ;
Rohmer, V ;
Sadoul, JL ;
Strompf, L ;
Schlumberger, M ;
Bertagna, X ;
Plouin, PF ;
Jeunemaitre, X ;
Gimenez-Roqueplo, AP .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (34) :8812-8818
[2]   CLONIDINE-SUPPRESSION TEST - A USEFUL AID IN THE DIAGNOSIS OF PHEOCHROMOCYTOMA [J].
BRAVO, EL ;
TARAZI, RC ;
FOUAD, FM ;
VIDT, DG ;
GIFFORD, RW .
NEW ENGLAND JOURNAL OF MEDICINE, 1981, 305 (11) :623-626
[3]  
BROWN MJ, 1981, LANCET, V1, P174
[4]  
BROWN MJ, 1981, BRIT J CLIN PHARMACO, V12, P251
[5]  
CHEW SL, 1994, Q J MED, V87, P49
[6]   TURNOVER + METABOLISM OF CATECHOLAMINES IN PATIENTS WITH PHEOCHROMOCYTOMA [J].
CROUT, JR ;
SJOERDSMA, A .
JOURNAL OF CLINICAL INVESTIGATION, 1964, 43 (01) :94-+
[7]   Phaeochromocytoma with normal urinary catecholamines: the potential value of urinary free metadrenalines [J].
Davidson, DF .
ANNALS OF CLINICAL BIOCHEMISTRY, 2002, 39 :557-566
[8]   PLASMA METADRENALINES - DO THEY PROVIDE USEFUL INFORMATION ABOUT SYMPATHOADRENAL FUNCTION AND CATECHOLAMINE METABOLISM [J].
EISENHOFER, G ;
FRIBERG, P ;
PACAK, K ;
GOLDSTEIN, DS ;
MURPHY, DL ;
TSIGOS, C ;
QUYYUMI, AA ;
BRUNNER, HG ;
LENDERS, JWM .
CLINICAL SCIENCE, 1995, 88 (05) :533-542
[9]   Biochemical and clinical manifestations of dopamine-producing paragangliomas: Utility of plasma methoxytyramine [J].
Eisenhofer, G ;
Goldstein, DS ;
Sullivan, P ;
Csako, G ;
Brouwers, FM ;
Lai, EW ;
Adams, KT ;
Pacak, K .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (04) :2068-2075
[10]   Pheochromocytoma catecholamine phenotypes and prediction of tumor size and location by use of plasma free metanephrines [J].
Eisenhofer, G ;
Lenders, JWM ;
Goldstein, DS ;
Mannelli, M ;
Csako, G ;
Walther, MM ;
Brouwers, F ;
Pacak, K .
CLINICAL CHEMISTRY, 2005, 51 (04) :735-744